GoodRx Holdings, Inc.

Ladies and gentlemen, thank you for your standby, and welcome to the GoodRx third quarter 2021 earnings call. As a reminder, today's conference call is being recorded. I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.

Thank you, Operator. Good afternoon, everyone. And welcome to GoodRx's earnings conference call for the third quarter of 2021. Joining me today are Doug Hirsch and Trevor Bezdak, our co-founders and co-chief executive officers, and Karsten Bowerman, our chief financial officer. Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements. including statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance, and the expected impact of COVID-19 on our business. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties, and other important factors. These factors may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statement. Factors discussed in the risk factor sections of our quarterly report on Form 10-Q for the quarter ended September 30th, 2021, an annual report on Form 10-K for the year ended December 31st, 2020, and our other filings with the Securities and Exchange Commission could cause actual results to differ materially from those indicated by the forward-looking statements made on this call. Any such forward-looking statements represent management's estimates as of the date of this call, and we disclaim any obligation to update these statements, even if subsequent events cause our views to change. In addition, we may also reference certain non-GAAP metrics, which are reconciled to the nearest GAAP metrics in a company's shareholder letter, which can be found on the overview page of our investor relations website at investors.goodrx.com. I'd also like to remind everyone that a replay of this call will become available there shortly as well. With that, I'll turn the call over to Doug.

Good afternoon, everybody, and thank you for joining us today. In September, GoodRx celebrated its 10-year anniversary. Over the past decade, we've worked hard to create ways to help millions of Americans access affordable care. Today, we support patients across each stage of their healthcare journey, delivering superior savings, trusted information, and access to care to millions of Americans. While many companies talk about making the world a better place, making a difference is what we do. GoodRx has now saved Americans $35 billion on their prescriptions, and consumer savings have increased to 80% off the pharmacy cash price. We beat insurance over 50% of the time, and we continue to increase access to brand drugs for our pharma manufacturer relationships. For many of our users, GoodRx is not just about saving money. It's about whether they will be able to buy their medication or their children's medication or not. In fact, we estimate that we have helped patients obtain at least 80 million prescriptions they otherwise may not have been able to afford. We believe that our impact has never been greater and with yet another quarter of record results that our business has never been stronger. Because of GoodRx, millions of Americans can now afford care. Because of GoodRx, millions of Americans are more informed and better prepared to make healthcare decisions from diagnosis to care delivery. And because of GoodRx, millions of patients are empowered to navigate the confusing world of healthcare, knowing they have a trusted advocate by their side. We continue building our broad and deep competitive mode, which is rooted in the trust we've established with patients, physicians, and companies across all of healthcare. Patients trust us, and our consumer NPS of 90 is a testament to the important role we play in their care. Physicians and healthcare professionals trust us with over 2 million prescribers that have a patient that has used GoodRx and a very high provider NPS of 90. Companies look to us as a way to introduce products and services and provide savings to our large and growing audience. We work with more PBMs and pharmacies than ever and have continued to strengthen those relationships. In addition to our 10-year anniversary in September, we also celebrated our one-year anniversary as a public company. we've made meaningful progress towards creating one of the leading digital consumer healthcare platforms over the last year and have substantially expanded our highly extensible platform to address more of the consumer healthcare journey for more Americans. We continue to address more of our TAM by enhancing our prescription savings offering through the acquisitions of Healthy Nation, RxSaver, and RxNext, launching brand drug integrated copay cards, expanding our gold network, entering into distribution agreements with DoorDash, USAA, and others, and establishing or continuing relationships with 95% of the top 20 pharma manufacturers in the U.S. We increased our diagnosis capabilities through the geographical and condition expansion of our telehealth services, rebranded them as GoodRx Care, and created a more unified user experience. We built significant capabilities to support consumers in the research and prevention stage of the healthcare journey through the acquisition of Healthy Nation and the launch of GoodRx Health. And finally, we made an exciting step into the insurance marketplace space through our relationship with GoHealth. This has all been fueled by the passion of our team and unrelenting dedication to our mission. Despite our success, Americans still face rising costs, decreasing life expectancy, and poorer health outcomes. We feel a tremendous sense of urgency to find more ways to help more people, and we believe that our efforts can help reverse those trends. In the coming years, we see more opportunities to help Americans fill more gaps in their healthcare journey including navigating insurance as their trusted advocate, further personalizing the GoodRx user experience, and extending our marketplace. We believe that we are just getting started and have barely scratched the surface of the opportunity to transform healthcare in the U.S. We won't rest until all Americans have access to affordable, high quality, and convenient healthcare. With that, I'll turn it over to Trevor to address key highlights from the quarter and trends in our business.